Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
3.192 EUR | -1.05% |
|
-1.78% | -32.37% |
07-01 | Valneva's Secures Marketing Authorization in Europe for Chikungunya Vaccine | MT |
07-01 | New semester, new state of mind | ![]() |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.37% | 485M | |
+16.59% | 44.44B | |
+41.82% | 39.84B | |
-10.62% | 37.68B | |
+29.92% | 31.46B | |
-9.78% | 27.02B | |
+12.34% | 26.29B | |
+41.53% | 13.8B | |
+31.49% | 12.46B | |
-7.40% | 11.26B |
- Stock Market
- Equities
- VLA Stock
- News Valneva
- Valneva's Secures Marketing Authorization in Europe for Chikungunya Vaccine